Table of Content


Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Gastric Cancer Drugs Market, by Region, 2018-2026 (USD Billion)
1.2.2. Gastric Cancer Drugs Market, by Route of Administration, 2018-2026 (USD Billion)
1.2.3. Gastric Cancer Drugs Market, by Lines of Chemotherapy, 2018-2026 (USD Billion)
1.2.4. Gastric Cancer Drugs Market, by Molecule Type, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Gastric Cancer Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Gastric Cancer Drugs Market Dynamics
3.1. Gastric Cancer Drugs Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Gastric Cancer Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Gastric Cancer Drugs Market, by Route of Administration
5.1. Market Snapshot
5.2. Global Gastric Cancer Drugs Market by Route of Administration, Performance - Potential Analysis
5.3. Global Gastric Cancer Drugs Market Estimates & Forecasts by Route of Administration 2016-2026 (USD Billion)
5.4. Gastric Cancer Drugs Market, Sub Segment Analysis
5.4.1. Oral
5.4.2. Parenteral
Chapter 6. Global Gastric Cancer Drugs Market, by Lines of Chemotherapy
6.1. Market Snapshot
6.2. Global Gastric Cancer Drugs Market by Lines of Chemotherapy, Performance - Potential Analysis
6.3. Global Gastric Cancer Drugs Market Estimates & Forecasts by Lines of Chemotherapy 2016-2026 (USD Billion)
6.4. Gastric Cancer Drugs Market, Sub Segment Analysis
6.4.1. First-line Chemotherapy
6.4.2. Second-line Chemotherapy
Chapter 7. Global Gastric Cancer Drugs Market, by Molecule Type
7.1. Market Snapshot
7.2. Global Gastric Cancer Drugs Market by Molecule Type, Performance - Potential Analysis
7.3. Global Gastric Cancer Drugs Market Estimates & Forecasts by Molecule Type 2016-2026 (USD Billion)
7.4. Gastric Cancer Drugs Market, Sub Segment Analysis
7.4.1. Small Molecule
7.4.2. Biologics
Chapter 8. Global Gastric Cancer Drugs Market, Regional Analysis
8.1. Gastric Cancer Drugs Market, Regional Market Snapshot
8.2. North America Gastric Cancer Drugs Market
8.2.1. U.S. Gastric Cancer Drugs Market
8.2.1.1. Route of Administration breakdown estimates & forecasts, 2016-2026
8.2.1.2. Lines of Chemotherapy breakdown estimates & forecasts, 2016-2026
8.2.1.3. Molecule Type breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Gastric Cancer Drugs Market
8.3. Europe Gastric Cancer Drugs Market Snapshot
8.3.1. U.K. Gastric Cancer Drugs Market
8.3.2. Germany Gastric Cancer Drugs Market
8.3.3. Rest of Europe Gastric Cancer Drugs Market
8.4. Asia-Pacific Gastric Cancer Drugs Market Snapshot
8.4.1. China Gastric Cancer Drugs Market
8.4.2. India Gastric Cancer Drugs Market
8.4.3. Japan Gastric Cancer Drugs Market
8.4.4. Rest of Asia Pacific Gastric Cancer Drugs Market
8.5. Latin America Gastric Cancer Drugs Market Snapshot
8.5.1. Brazil Gastric Cancer Drugs Market
8.5.2. Mexico Gastric Cancer Drugs Market
8.6. Rest of The World Gastric Cancer Drugs Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Amgen
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. AROG Pharmaceuticals
9.2.3. Ipsen Biopharmaceuticals
9.2.4. Array Biopharma
9.2.5. Taiho Oncology
9.2.6. AstraZeneca
9.2.7. ARIAD Pharmaceuticals
9.2.8. Eli Lilly
9.2.9. Galena Biopharma
9.2.10. ASLAN Pharmaceuticals
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption



List of Figures


FIG 1. GLOBAL GASTRIC CANCER DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL GASTRIC CANCER DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL GASTRIC CANCER DRUGS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL GASTRIC CANCER DRUGS MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL GASTRIC CANCER DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL GASTRIC CANCER DRUGS MARKET, PEST ANALYSIS
FIG 8. GLOBAL GASTRIC CANCER DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL GASTRIC CANCER DRUGS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA GASTRIC CANCER DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE GASTRIC CANCER DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC GASTRIC CANCER DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA GASTRIC CANCER DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL GASTRIC CANCER DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)


List of Tables


TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL GASTRIC CANCER DRUGS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL GASTRIC CANCER DRUGS MARKET
TABLE 3. GLOBAL GASTRIC CANCER DRUGS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY ROUTE OF ADMINISTRATION 2016-2026 (USD BILLION)
TABLE 8. GLOBAL GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY LINES OF CHEMOTHERAPY 2016-2026 (USD BILLION)
TABLE 9. GLOBAL GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY MOLECULE TYPE 2016-2026 (USD BILLION)
TABLE 10. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL GASTRIC CANCER DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL GASTRIC CANCER DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL GASTRIC CANCER DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL GASTRIC CANCER DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL GASTRIC CANCER DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL GASTRIC CANCER DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. U.S. GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. CANADA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. CANADA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. CANADA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. UK GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. UK GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. UK GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. GERMANY GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. GERMANY GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. GERMANY GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. ROE GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. ROE GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. ROE GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. CHINA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. CHINA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. CHINA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. INDIA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. INDIA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. INDIA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. JAPAN GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. JAPAN GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. JAPAN GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. ROAPAC GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. ROAPAC GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. ROAPAC GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. BRAZIL GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 48. BRAZIL GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. BRAZIL GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. MEXICO GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 51. MEXICO GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. MEXICO GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. ROLA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 54. ROLA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROLA GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROW GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 57. ROW GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. ROW GASTRIC CANCER DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)